To see the other types of publications on this topic, follow the link: Ral GTP-Binding Proteins.

Dissertations / Theses on the topic 'Ral GTP-Binding Proteins'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 34 dissertations / theses for your research on the topic 'Ral GTP-Binding Proteins.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse dissertations / theses on a wide variety of disciplines and organise your bibliography correctly.

1

Winge, Per. "The evolution of small GTP binding proteins in cellular organisms. Studies of RAS GTPases in arabidopsis thaliana and the Ral GTPase from Drosophila melanogaster." Doctoral thesis, Norwegian University of Science and Technology, Faculty of Natural Sciences and Technology, 2002. http://urn.kb.se/resolve?urn=urn:nbn:no:ntnu:diva-169.

Full text
Abstract:

Small GTP binding proteins function as molecular switches which cycles between GTP-bound ON and GDP-bound OFF states, and regulate a wide variety of cellular processes as biological timers. The first characterized member of the small GTPase family, the mutated oncogene p21 src, later known as Harvey-Ras, was identified in the early 1980s (Shih, T. Y. et al. 1980). In the following years small Ras-lik GTPases were found in several organisms and it was soon discovered that they took part in processes, such as signal transduction, gene expression, cytoskeleton reorganisation, microtubule organisation, and vesicular and nuclear transport. The first Rho (Ras homology) gene was cloned in 1985 from the sea slug Aplysia (Madaule, P. et al. 1985) and because of their homology to Ras it was first suspected that they could act as oncogenes. Later studies have shown that even though they participate in processes such as cell migration and motility they are not mutated in cancers.

The first indications that Rho was a signaling protein regulating the actin cytoskeleton, came from experiments where activated forms of human RhoA was microinjected into 3T3 cells (Paterson, H. F. et al. 1990). Another Rho-like GTPase Rac1 (named after Ras-related C3 botulinum toxin substrate) was later shown to regulate actin cytoskeletal dynamics as well, suggesting that Rho-family members cooperate in controlling these processes (Ridley, A. J. et al. 1992). The Rac GTPase was also implicated in regulating the phagocytic NADPH oxidase, which produce superoxide for killing phagocytized microorganisms (Abo, A. et al. 1991). Thus, it soon became clear that Rac/Rho and the related GTPase Cdc42 (cell division cycle 42) had central functions in many important cellular processes.

There are at least three types of regulators for Rho-like proteins. The GDP/GTP exchange factors (GEFs) which stimulates conversion from the GDPbound form to the GTP-bound form. GDP dissociation inhibitors (GDIs) decrease the nucleotide dissociation from the GTPase and retrieve them from membranes to the cytosol. GTPase activating proteins (GAPs) stimulates the intrinsic GTPase activity and GTP hydrolysis. In addition there are probably regulators that dissociate GDI from the GTPase leaving it open for activation by the RhoGEFs.

Ras and Rho-family proteins participate in a coordinated regulation of cellular processes such as cell motility, cell growth and division. The Ral GTPase is closely related to Ras and recent studies have shown that this GTPase is involved in crosstalk between both Ras and Rho proteins (Feig, L. A. et al. 1996; Oshiro, T. et al. 2002). Ral proteins are not found in plants and they appear to be restricted to animalia and probably yeast. During a screen for small GTPases in Drosophila melanogaster I discovered in 1993 several new members of the Ras-family, such as Drosophila Ral (DRal), Ric1 and Rap2. The functions of Ral GTPases in Drosophila have until recently been poorly known, but in paper 2 we present some of the new findings.

Rho-like GTPases have been identified in several eukaryotic organisms such as, yeast (Bender, A. et al. 1989), Dictyostelium discoideum (Bush, J. et al. 1993), plants (Yang, Z. et al. 1993), Entamoeba histolytica (Lohia, A. et al. 1993) and Trypanosoma cruzi (Nepomuceno-Silva, J. L. et al. 2001). In our first publication, (Winge, P. et al. 1997), we describe the cloning of cDNAs from RAC-like GTPases in Arabidopsis thaliana and show mRNA expressions pattern for five of the genes. The five genes analyzed were expressed in most plant tissues with the exception of AtRAC2 (named Arac2 in the paper), which has an expression restricted to vascular tissues. We also discuss the evolution and development of RAC genes in plants. The third publication, (Winge, P. et al. 2000), describe the genetic structure and the genomic sequence of 11 RAC genes from Arabidopsis thaliana. As most genomic sequences of the AtRACs we analyzed came from the Landsberg erecta ecotype and the Arabidopsis thaliana genome was sequenced from the Columbia ecotype, it was possible to compare the sequences and identify new polymorphisms. The genomic location of the AtRAC genes plus the revelation of large genomic duplications provided additional information regarding the evolution of the gene family in plants. A summary and discussion of these new findings are presented together with a general study of small Ras-like GTPases and their evolution in cellular organisms. This study suggests that the small GTPases in eukaryots evolved from two bacterial ancestors, a Rab-like and a MglA/Arp-like (Arf-like) protein. The MglA proteins (after the mgl locus in Myxococcus xanthus) are required for gliding motility, which is a type of movement that take place without help of flagella.

The second publication describes experiments done with the Drosophila melanogaster DRal gene and its effects on cell shape and development. Ectopic expression of dominant negative forms of DRal reveals developmental defects in eye facets and hairs, while constitutive activated forms affects dorsal closure, leaving embryos with an open dorsal phenotype. Results presented in this publication suggest that DRal act through the Jun N-terminal kinase (JNK) pathway to regulate dorsal closure, but recent findings may point to additional explanations as well. The results also indicate a close association between processes regulated by Rac/Rho and Ral proteins in Drosophila.

APA, Harvard, Vancouver, ISO, and other styles
2

Falsetti, Samuel C. "The Role of RalA and RalB in Cancer." [Tampa, Fla] : University of South Florida, 2008. http://purl.fcla.edu/usf/dc/et/SFE0002307.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bramble, Sharyl Elizabeth. "Guanine nucleotide binding properties and attempted immunopurification of ras protein from dictyostelium discoideum." Thesis, University of British Columbia, 1987. http://hdl.handle.net/2429/26172.

Full text
Abstract:
One purpose of this study was to determine whether the ras protein from Dictyostelium discoideum (p23) binds guanine nucleotides like the ras proteins from mammals (p21) and yeast. The other purpose of this investigation was to purify or enrich for p23ras from D. discoideum by immunoaffinity chromatography. A number of different approaches were used to determine guanine nucleotide binding by p23RAS . A simple filter binding assay, binding to Western blots, and photoaffinity labeling all failed to demonstrate specific binding with lysates of D. discoideum cells. In contrast p21RAS from transformed NIH-3T3 cell lysate was successfully photoaffinity labeled in the presence of ³²P-α-guanosine 5¹-triphosphate (GTP) suggesting that the technique had been performed correctly. It was concluded that either p23RAS has a very low affinity for guanine nucleotides such that GTP binding was not detectable in these experiments or that the ras protein from D. discoideum simply does not bind guanine nucleotides. The purification of p23RAS from D. discoideum cells was attempted in order to provide a purified protein preparation for guanine nucleotide binding and for reconstitution studies. An anti-ras monoclonal antibody (Y13-259) was used as the ligand for the immunoaffinity chromatography. This approach was not successful in that the ras protein could not be enriched relative to other proteins because the immunoaffinity columns did not bind p23RAS.
Science, Faculty of
Microbiology and Immunology, Department of
Graduate
APA, Harvard, Vancouver, ISO, and other styles
4

Gibson, Janet Rae. "A study of RAS p21 and related GTP-binding proteins." Thesis, University of East Anglia, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.293243.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Seibold, Marcel [Verfasser], Ralf C. [Gutachter] Bargou, and Thomas [Gutachter] Dandekar. "Funktionelle Charakterisierung des Ras family small GTP binding protein RAL im Multiplen Myelom / Marcel Seibold ; Gutachter: Ralf C. Bargou, Thomas Dandekar." Würzburg : Universität Würzburg, 2020. http://d-nb.info/1214181007/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Seibold, Marcel Verfasser], Ralf C. [Gutachter] [Bargou, and Thomas [Gutachter] Dandekar. "Funktionelle Charakterisierung des Ras family small GTP binding protein RAL im Multiplen Myelom / Marcel Seibold ; Gutachter: Ralf C. Bargou, Thomas Dandekar." Würzburg : Universität Würzburg, 2020. http://nbn-resolving.de/urn:nbn:de:bvb:20-opus-208003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Scapin, Sandra Mara Naressi. "Analises estruturais de GTPases da familia RAB e mecanismo de regulção de MAFB pela proteina TIPRL." [s.n.], 2007. http://repositorio.unicamp.br/jspui/handle/REPOSIP/317183.

Full text
Abstract:
Orientadores: Nilson Ivo Tonin Zanchin, Beatriz Gomes Guimaraes
Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia
Made available in DSpace on 2018-08-09T09:39:45Z (GMT). No. of bitstreams: 1 Scapin_SandraMaraNaressi_D.pdf: 11335048 bytes, checksum: 153f9eea9142fb7f3cb17de59a608da6 (MD5) Previous issue date: 2007
Resumo: As GTPases da família Rab regulam o transporte intracelular de vesículas em eucariotos. Cada Rab atua em uma via de transporte específica e seu mecanismo de ação se dá através da realização de um ciclo de ligação e hidrólise de GTP. Neste trabalho, foi determinada a estrutura cristalográfica das formas inativa (ligada a GDP) e ativa (ligada a GppNHp) da GTPase Rab11b, um membro da subfamília Rab11 que está envolvida na reciclagem de proteínas dos endossomos para a membrana plasmática, no tráfego de vesículas da rede trans-Golgi para a membrana plasmática e na fagocitose. Os resultados foram confrontados com os dados estruturais da Rab11a descritos anteriormente. A Rab11b inativa cristalizou como um monômero, o que gera conflitos a respeito da formação de dímeros funcionais pela Rab11a. A Rab11b e a Rab11a ativas divergiram em relação à posição e à interação da serina 20, que é importante na hidrólise de GTP, mas apresentaram taxas hidrolíticas semelhantes in vitro. Visando uma investigação mais ampla da família Rab, a GTPase Rab21 também foi cristalizada, mas os cristais difrataram até 2.90 Å de resolução. Ensaios de desnaturação térmica revelaram que a Rab21 é estruturalmente mais instável do que a Rab11, talvez pela presença de cisteínas que estão susceptíveis à oxidação, contribuindo para a agregação e precipitação da proteína. A Rab11 é bastante estável, e possivelmente forma estruturas do tipo beta-amilóide em altas temperaturas. Este trabalho envolveu também o estudo funcional da interação entre a proteína TIP41 humana (TIPRL) e o fator de transcrição MafB. A TIPRL é uma proteína conservada que foi identificada como uma ativadora de MAP quinases enquanto sua homóloga em levedura foi caracterizada como um antagonista da via de sinalização da quinase TOR que regula o crescimento celular. A MafB está envolvida no controle transcricional em diversos processos de desenvolvimento, mas seus reguladores ainda não estão bem estabelecidos. A interação direta entre a TIPRL e a MafB inteira, ou seu domínio bZIP isolado, foi confirmada através de ensaios de ligação in vitro. As proteínas co-localizaram no núcleo de células HEK293 e nossos resultados preliminares mostram que a TIPRL inibe a atividade transcricional da MafB in vivo, embora apenas interfira na ligação in vitro do domínio bZIP da MafB ao seu DNA-alvo mediante a estabilização do complexo TIPRL-bZIP. A TIPRL pode, portanto, constituir um novo regulador da atividade de MafB
Abstract: GTPases of the Rab family are responsible for the intracellular transport of vesicles. Each family member acts on a specific transport pathway and their function is regulated by GTP binding and hydrolysis, cycling between inactive (GDP-bound) and active (GTP-bound) forms. In this work, we describe the crystal structure of inactive and active forms of the GTPase Rab11b, a member of the Rab11 subfamily which is involved in recycling of proteins from endosomes to the plasma membrane, in polarized transport in epithelial cells, in the transport of molecules of the trans-Golgi network to the plasma membrane and in phagocytosis. The Rab11b structure showed several differences from the Rab11a isoform previously described. Inactive Rab11b crystallized as a monomer, contradicting the hypothesis about functional dimers formed by Rab11a. Active Rab11b differ from Rab11a relative to the position of the serine 20 sidechain, which is involved in GTP hydrolysis, although both GTPases show similar GTP hydrolysis rates in vitro. In order to obtain structural information on Rab GTPases, Rab21 was also crystallized, but the crystals diffracted to a relatively low resolution (2.90 Å). Rab21 is a cysteine rich protein, showing a higher instability relative to Rab11b. Thermal unfolding followed by circular dicroism confirmed this hypothesis. Both Rab11b and Rab11a show a relatively high thermal stability and circular dicroism analysis indicate that they undergo conversion to structures rich in beta-strands upon thermal denaturation. This work includes also studies on the function of TIPRL in regard to its interaction with the transcription factor MafB. TIPRL is a conserved human protein identified as an activator of MAP kinases whereas its yeast counterpart Tip41 functions as an antagonist of the TOR kinase pathway. MafB is a large member of the Maf family of bZIP transcription factors controlling developmental processes in vertebrates. Regulation of MafB is critical, for example, during erythroid differentiation. A direct interaction between TIPRL and full length MafB and the bZIP domain of MafB was confirmed by in vitro interaction assays. TIPRL is localized throughout the whole cell and overlaps with MafB in the nucleus of HEK293 cells. Preliminary assays showed that TIPRL inhibits transcriptional activation mediated by MafB in HEK293 cells, although MafB shows a higher binding affinity to its target DNA relative to TIPRL in vitro. This evidence indicates that TIPRL may control MafB activity in vivo
Doutorado
Genetica Animal e Evolução
Doutor em Genetica e Biologia Molecular
APA, Harvard, Vancouver, ISO, and other styles
8

Tuxworth, Richard Ian. "The control of cell motility and differentiation by Ras pathways." Thesis, University College London (University of London), 1999. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.314227.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Self, Annette Jane. "Structural and functional analysis of Ras and Ruo-related small GTP-binding proteins." Thesis, Institute of Cancer Research (University Of London), 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.266353.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Diekmann, Dagmar. "Structural and functional analysis of the small GTP-binding proteins rho and rac." Thesis, Institute of Cancer Research (University Of London), 1995. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.283195.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Bryan, Steven. "Rho/Rac GTP-binding proteins and their GTPase activating proteins in humans and in Dictyostelium discoideum." Thesis, University College London (University of London), 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.266164.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

D'Silva, Nisha Jacinta. "Rap1, a small GTP-binding protein in the rat parotid gland : identification, investigation of function and regulation /." Thesis, Connect to this title online; UW restricted, 1997. http://hdl.handle.net/1773/6388.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Vanlandingham, Phillip Allen. "Rab7 regulation of EGFR trafficking and signaling." Oklahoma City : [s.n.], 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Gandhi, Payal. "Characterization of the Parkinson's disease associated protein, leucine-rich repeat kinase 2 (LRRK2), as a Ras-related GTPase." Cleveland, Ohio : Case Western Reserve University, 2007. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=case1195574448.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Adhikari, Anirban. "Regulation of guanine nucelotide exchange in inhibitory G protein alpha subunit by activator of G protein signaling 3 and novel regulatory peptides." Embargoed access until after 12/19/2006, 2005. http://www4.utsouthwestern.edu/library/ETD/etdDetails.cfm?etdID=114.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Shao, Xingguo. "Identification of a Tans-differentiation factor, Rad, a small Ras-like GTP-binding protein, in the regulation of epithelial cell differentiation in human airway epithelium /." For electronic version search Digital dissertations database. Restricted to UC campuses. Access is free to UC campus dissertations, 2003. http://uclibs.org/PID/11984.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Macdonald, Susan G. "G Protein Interactions with the Substance P Receptor in Rat Submaxillary Gland: a Dissertation." eScholarship@UMMS, 1991. http://escholarship.umassmed.edu/gsbs_diss/268.

Full text
Abstract:
Substance P (SP) is an undecapeptide whose functions are as varied as its locations. In the nervous system, it is thought to act as a neurotransmitter. In the peripheral vasculature, it has hypotensive effects and it causes contraction in the smooth muscle of the gut. In salivary gland, it is a potent secretagogue and it is how this effect is transduced that is the subject of this dissertation. Activation of the SP receptor in rat submaxillary gland by SP results in the hydrolysis of inositol phospholipids and the mobilization of intracellular Ca2+. These second messengers are then able to activate a pathway(s) which results in the secretion of electrolytes, water and macromolecules. The production of these second messengers, however, is thought to require the participation of a guanine nucleotide binding protein (G protein). The G protein that couples to the SP receptor (Gp), has not yet been identified. Although several investigators have recently reported the purification of G protein α subunits that are capable of activating phospholipase C, it is not known if they couple to receptors in order to activate phospholipase C. In an effort to learn more about the mechanisms of signal transduction by SP in salivary gland, the interactions of the SP receptor with G proteins were studied. In the first study, the question of whether the SP receptor functionally couples to a G protein was investigated. Alkaline treatment was used to deplete membranes containing SP receptors of endogenous G proteins. These membranes were not capable of binding SP with high affinity. High affinity binding capability was restored in those membranes, however, by reconstituting them with exogenous G proteins. Thus, it was concluded that that SP receptor agonist affinity is regulated by a G protein. It was also determined that the G proteins (a Go/Gi mixture) used to reconstitute the membranes may not be those that couple to the SP receptor in vivo, since the reconstituted Go/Gi mixture was inactivated by treatment with pertussis toxin, while Gp was not. The next study was undertaken in an effort to identify other G proteins that are able to interact with the SP receptor. G proteins were chromatographically purified from horse submaxillary gland membranes, and assayed for characteristics that could identify one or more G proteins as potential physiological couplers to the SP receptor. G proteins were identified in fractions by the ability to bind [35S]GTPγS. These GTP-binding proteins were further characterized by testing their susceptibility to ADP- ribosylation catalyzed by pertussis toxin and their ability to restore high affinity agonist binding in membranes containing the SP receptor, but no endogenous G proteins. In addition to identifying G proteins that are substrates for pertussis toxin-catalyzed ADP-ribosylation (e.g. Go and/or Gi), a GTP-binding protein was identified which possesses characteristics that are unlike those of the well-known G proteins, Go, Gi and Gs. This protein elutes from anion exchange resins at a high salt concentration, is not susceptible to ADP- ribosylation catalyzed by pertussis toxin, is able to reconstitute high affinity binding in G protein depleted rat submaxillary gland membranes and is not recognized by antibodies to Go, Gi, Gs or Gz. Finally, a direct characterization of the G protein coupled to the SP receptor in rat submaxillary gland was undertaken. Using photo-affinity labelling techniques in conjunction with chemical crosslinking techniques, a covalent 96 kDa SP receptor complex was identified. The generation of this 96 kDa complex was inhibited by a nonhydrolyzable analog of GTP, but not a nonhydrolyzable analog of ATP. Furthermore, the complex could not be produced in membranes that had been depleted of G proteins by alkaline treatment. Reversal of the chemical crosslink yielded only the 53 kDa SP receptor, showing that the protein crosslinking to the SP receptor possesses a molecular weight of about 43 kDa. This molecular weight is typical of G protein α subunits. It was concluded that the 96 kDa crosslinked receptor complex consisted of the SP receptor, the radioiodinated SP derivative and the α subunit of Gp. The studies show that the SP receptor may be coupled to a novel G protein, whose purification characteristics differ from those of the known G proteins. Although Gp has yet to be identified, comparisons of the results of these investigations with those of several recent articles in which the purification of G protein α subunits that are capable of stimulating phospholipase C is reported, suggests that Gp is similar, if not identical to those proteins. Furthermore, this dissertation describes a unique reconstitution system and crosslinking techniques which should prove useful in the identification of Gp, as well as in the study of other receptor-G protein interactions and perhaps, the reconstitution of the receptor-G protein-phospholipase C signal transduction pathway.
APA, Harvard, Vancouver, ISO, and other styles
18

Simon, Glenn C. "Endosomes and mitosis : FIP3-associated vesicle delivery during cytokinesis /." Connect to abstract via ProQuest. Full text is not available online, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Warren-Paquin, Maude. "Regulation of synaptic plasticity at the Drosophila larval NMJ : the role of the small GTPase Rac." Thesis, McGill University, 2008. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=112319.

Full text
Abstract:
We are interested in understanding the molecular mechanisms that govern synaptic growth and plasticity. Recent evidence from several laboratories suggests that small GTPases play an important role in the promotion of neurite outgrowth; however, their role in the control of synaptic growth and functional plasticity is not well understood. The goal of this thesis is to investigate the role of small GTPases (including Rac, Rho and Cdc42) in the regulation of synaptic growth in vivo, using the Drosophila larval neuromuscular junction (NMJ) synapses as a model system. Our results show that presynaptic overexpression of Rac, but not of Rho or Cdc42, positively regulates both synaptic structure and function. Genetic loss of Rac leads to embryonic lethality, making it impossible to assess the full loss-of-function phenotype using conventional mutants. To circumvent this, we use the MARCM (Mosaic Analysis with a Repressible Cell Marker) technique to generate single motor neuron clones devoid of all genetic copies of Rac. Our data suggest that Rac activity is crucial for normal synaptic development. In support of this conclusion, we demonstrate that genetic removal of trio, a guanine nucleotide exchange factor (GEF) that is known to activate Rac, leads to a drastic reduction in the number of synaptic boutons. In addition, genetic removal of one copy of trio is sufficient to suppress the gain-of-function phenotype of Rac. Moreover, we demonstrate that partial removal of the fragile X mental retardation gene (dfmr1), a known suppressor of Rac, enhances the gain-of-function phenotype of Rac. Taken together, our findings support a model in which Rac signaling positively regulates synaptic growth and function at the Drosophila larval NMJ.
APA, Harvard, Vancouver, ISO, and other styles
20

Barrett, Curtis F. "Modulation of N-type Calcium Channels in Rat Superior Cervical Ganglion Neurons: A Dissertation." eScholarship@UMMS, 2001. https://escholarship.umassmed.edu/gsbs_diss/144.

Full text
Abstract:
This thesis details my examination of several mechanisms for modulation of N-type calcium channels in neonatal rat superior cervical ganglion (SCG) neurons. The first part of this work characterizes cross-talk between two distinct mechanisms of modulation: readily-reversible inhibition induced by activation of heterotrimeric G-proteins (termed G-protein-mediated inhibition), and phosphorylation of the channel by protein kinase C (PKC). Data previously presented by other groups suggested that one effect of activating PKC is to prevent G-protein-mediated inhibition. The goal of this project was to confirm this hypothesis by testing functional competition between these two pathways. My findings show that G-protein-mediated inhibition blocks the effects of activating PKC, and that phosphorylation by PKC blocks G-protein-mediated inhibition, confirming that these two mechanisms are mutually exclusive. In addition, I investigated the effect of activating PKC on whole-cell barium currents in the absence of G-protein-mediated inhibition. When endogenous G-proteins were inactivated by dialyzing the cell with GDP-β-S, a guanine nucleotide that prevents activation of the G-protein's α subunit, activation of PKC with phorbol esters was without obvious effect on whole-cell current amplitude, fast and holding potential-dependent inactivation, and voltage-dependent activation, suggesting that PKC's principal role in modulating these currents is to prevent G-protein-mediated inhibition. From these results, I advanced Bean's 1989 model of reluctant and willing gating (induced by G-protein-mediated inhibition and relief of that inhibition, respectively). In this expanded model, reluctant channels, inhibited by G-proteins, are resistant to phosphylation by PKC (reluctant/P-resistant). Unmodulated channels are called willing/available, as they exhibit willing gating, and are available for either binding to a G-protein or phosphorylation by PKC. Finally, phosphorylation of a willing/available channel by PKC drives the channel into the willing/G-resistant state, in which the channel gates willingly, and is resistant to G-protein-mediated inhibition. These results are published in the Journal of General Physiology(2000; 115:277-286), and are presented in this thesis as Chapter II. In addition to membrane-delimited inhibition, N-type calcium channels are also subject to inhibition via a diffusible second-messenger pathway. In SCG neurons, this inhibition can be observed following stimulation of M1 muscarinic receptors by the agonist oxotremorine-M. Our lab previously hypothesized that the diffusible messenger involved might be the polyunsaturated fatty acid arachidonic acid (AA). To test this hypothesis, our lab examined the effect of bath-applied AA on whole-cell SCG calcium currents, and demonstrated that AA induces inhibition with similar properties as M1 muscarinic inhibition. An analysis of AA's effects on unitary N-type calcium currents, published by Liu and Rittenhouse in Journal of Physiology(2000; 525:391-404), revealed that this inhibition is mediated, at least in part, by both a significant increase in the occurrence of null-activity sweeps and a significant decrease in mean closed dwell time. Based on these results, our lab conducted an examination of AA's effects on whole-cell currents in SCG neurons, and found that AA-induced inhibition is mediated by an increase in holding potential-dependent inactivation and appears independent of AA metabolism. When I examined AA's effects in greater detail, I discovered that, in addition to inhibition, AA also appeared to cause significant enhancement of whole-cell currents. The results characterizing AA's general effects on whole-cell calcium currents in SCG neurons have been published in American Journal of Physiology - Cell Physiology(2001; 280:C1293-C1305). Because my finding that AA enhances whole-cell neuronal calcium currents revealed a novel pathway through which this current can be modulated, I proceeded to characterize this effect. My results showed that enhancement develops significantly faster than inhibition, suggesting different mechanisms or pathways. In addition, dialyzing the cell with BSA, a protein that binds fatty acids, blocked the majority of AA-induced inhibition, but did not reduce enhancement, suggesting that enhancement is independent of inhibition and might be mediated at an extracellular site. Using fatty acid analogs that cannot cross the cell membrane, I confirmed that enhancement occurs extracellularly. My data also indicate that AA-induced enhancement of whole-cell currents does not require metabolism of AA, consistent with enhancement being mediated directly by AA. I also examined the biophysical characteristics of enhancement, and found that both an increase in the voltage sensitivity of activation and an increase in activation kinetics underlie this effect. Finally, using both pharmacological agents and a recombinant cell line, I presented the first demonstration that AA enhances N-type calcium current. These findings are described in detail in a paper recently published in American Journal of Physiology - Cell Physiology(2001; 280:C1306-C1318), and are presented in this thesis as Chapter III. In our investigation of AA's effects on whole-cell calcium currents, we utilized a voltage protocol, in conjunction with pharmacology, to enhance the level of L-type current in these cells. Since whole-cell calcium currents in SCG neurons are comprised of mostly (80-85%) N-type current, with the remaining current comprised of mostly L-type current, this approach allowed us to examine both N- and L-type currents. When currents are recorded in the presence of 1 μM FPL 64174 (FPL), a benzoyl pyrrole L-type calcium channel agonist first described in 1989, stepping the membrane potential to -40 mV following a test pulse to +10 mV generates a slowly-deactivating ("tail") current. This tail current is made up entirely of L-type current, and allows us to readily investigate the effect of various modulatory mechanisms on this current type. Although FPL has been used for almost a decade to study L-type calcium currents, activity of FPL on N-type calcium currents has not been investigated. Because our lab routinely uses micromolar concentrations of FPL to measure whole-cell and unitary calcium currents in neuronal cells, I tested whether FPL has any effects on N-type calcium current. Therefore, I examined the effect of FPL on whole-cell calcium currents in an HEK 293 cell line that expresses recombinant N-type calcium channels. Application of 1 and 10 μM FPL caused significant, voltage-independent inhibition of currents, demonstrating that FPL inhibits N-type calcium current. Thus, at micromolar concentrations, FPL is not selective for L-type calcium current, and any examination of its effects on whole-cell calcium currents should take this into account. The results describing FPL's effects on L- and N-type calcium currents are included in a manuscript currently in preparation, and are presented as Chapter IV.
APA, Harvard, Vancouver, ISO, and other styles
21

Lee, Meng-Tse. "Catalytic Mechanisms in Sec7 and Vps9 Domain Exchange Factors for Arf and Rab GTPases: A Dissertation." eScholarship@UMMS, 2012. https://escholarship.umassmed.edu/gsbs_diss/598.

Full text
Abstract:
Vesicle budding, membrane trafficking, and lipid metabolism depend on the switching of Arf and Rab GTPases from the inactive GDP bound state to the active GTP bound state. However, Arf and Rab GTPases have intrinsic rates of GDP to GTP exchange that are much slower (hours to days) than the time scale of the relevant trafficking processes (seconds or less). In cells, the activation of Arf and Rab GTPases is tightly regulated by guanine nucleotide exchange factors (GEFs) with Sec7 or Vps9 domains, respectively. Full length Cytohesins, which have a domain architecture consisting of heptad repeats, a Sec7 domain, a pleckstrin homology (PH) domain, and a polybasic motif, have 100-fold lower exchange activity than the isolated Sec7 domain. Insights into the low exchange activity were obtained by structural, biochemical and kinetic analyses. It was found that the Sec7-PH domain linker and a C-terminal amphipathic helix physically block the docking sites for the switch regions of Arf GTPases. Mutations within either element result in partial or complete relief of autoinhibition. Autohibition is also strongly relieved by phosphorylation of protein kinase C (PKC) sites in the polybasic motif of Cytohesin-1 or by phosphoinositide head group-dependent binding of active Arf6. Despite unrelated folds, Sec7 and Vps9 domains engage cognate GTPases in a strikingly similar manner and supply a critical acidic residue that interacts with an invariant lysine residues from phosphate binding (P) loop of the GTPase in the nucleotide free complex. The key acidic residues have also been proposed to disrupt the Mg2+ binding site; however, it is not known whether disruption of Mg2+ binding contributes to the rate limiting step for nucleotide release. To investigate the kinetic mechanism for catalysis of nucleotide exchange in the absence of autoinhibitory interactions, a detailed stopped flow kinetic analysis of the intrinsic and GEF mediated exchange reactions was conducted for the isolated catalytic cores. Using three different fluorescence methods to monitor Mg2+ dissociation, formation of the nucleotide free intermediate, and subsequent nucleotide binding, the catalytic cores of Cytohesin-1 and Rabex-5 were found to robustly accelerate nucleotide exchange on Arf1 and Rab5, respectively, by at least 105- fold at physiological concentrations of Mg2+. The acceleration of nucleotide exchange was reduced by roughly an order of magnitude at sub-micromolar concentrations of Mg2+. In addition, the Cytohesin-1 and Rabex-5 catalytic cores have similarly high catalytic efficiencies (kcat/KM) as well as high lower limits on both the rate (kcat) and steady state (KM) constants for GDP release at physiological as well as low Mg2+ concentration. The limits on kcat and KM are comparable to the highest values reported for other well characterized GEFs and likely reflect dual requirements of membrane targeting and autoregulatory mechanisms for tight control of catalytic output. These results provide a solid structural and mechanistic foundation for future experiments to investigate the spatial-temporal dynamics of Cytohesin and Rabex-5 activation in cellular contexts.
APA, Harvard, Vancouver, ISO, and other styles
22

Davis, Jon Michael. "The modulation of polymorphonuclear neutrophil function by cytotoxic necrotizing factor type 1 -- expressing uropathogenic Escherichia coli /." Download the dissertation in PDF, 2005. http://www.lrc.usuhs.mil/dissertations/pdf/JDavis2005.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Cheng, Ling. "MOLECULAR MECHANISM OF L1CAM FUNCTION: AXON GROWTH AND GUIDANCE." Connect to online version, 2004. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=case1081281361.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Carie, Adam E. "Tumor suppressive effects of the Beta-2 adrenergic receptor and the small GTPase RhoB." [Tampa, Fla.] : University of South Florida, 2008. http://purl.fcla.edu/usf/dc/et/SFE0002330.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Farizatto, Karen Lisneiva Garcia. "Estudo da degradação da proteína Tau hiperfosforilada por vias independentes do proteassoma, em modelo experimental de neurodegeneração." Universidade de São Paulo, 2014. http://www.teses.usp.br/teses/disponiveis/5/5160/tde-09122014-133659/.

Full text
Abstract:
O desenvolvimento das doenças neurodegenerativas, como a doença de Alzheimer, está associado à presença de agregados proteicos contendo Tau hiperfosforilada (p-Tau). Esta disfunção da Tau leva a prejuízos na homeostase celular. Um mecanismo chave para diminuir e/ou prevenir os danos promovidos pelos agregados contendo Tau seria o estímulo de sua degradação. Neste sentido, a proposta do presente estudo foi analisar a degradação da proteína Tau após aumento da expressão exógena da cochaperona Bag-2, a qual influencia o sistema proteassomal de degradação; bem como avaliar a ativação dos sistemas de degradação, a fim de correlacionar estes sistemas em cultura de células primárias e organotípica do hipocampo de ratos. Os resultados mostraram que a rotenona foi capaz de aumentar os níveis de p-Tau e que a superexpressão de Bag-2, foi eficiente em prevenir e degradar a p-Tau. O mecanismo envolvido neste processo envolve a coordenação dos sistemas proteassomal e lisossomal, já que a Rab7 e a Rab24 (envolvidas na via lisossomal) mostraram-se diminuídas na fase que antecede a agregação proteica, enquanto houve aumento da Rab24 na presença dos agregados proteicos. Com relação ao peptídeo beta amiloide, foi demonstrado tendência de aumento de p-Tau acompanhado de diminuição da atividade proteassomal e lisossomal. O tratamento com PADK (ativador lisossomal) foi capaz de reverter este efeito nestas diferentes condições. A análise da interrelação entre os sistemas mostrou que uma inibição do proteassoma favorece a via lisossomal e que o inverso não se repete. Os resultados sugerem que a modulação das vias de degradação pode ser interessante para o estudo, prevenção e tratamento das doenças neurodegenerativas associadas à agregação de proteínas
Neurodegenerative diseases, such as Alzheimer\'s, are associated to protein inclusions containing hyperphosphorylated Tau (p-Tau). It is well established that Tau dysfunction impairs cell homeostasis. A key mechanism to prevent and/or reduce the damage promoted by aggregates of Tau might be its degradation. In view of this, the aims of the present study are to evaluate p- Tau clearance following exogenous expression of Bag-2, which stimulates proteasome; as well as to analyze the activation of both lysosome and proteasome pathways in order to understand the crosstalk between these two systems in primary and organotypic cultures of rat hippocampus. Results showed that rotenone was able of increasing p-Tau that was prevented and degraded by Bag-2 overexpression. Mechanisms involved in this process involve the coordination of cell degradation systems, depending upon aggregation status, since Rab7 and Rab24 (involved in lysosomal pathway) were decreased before protein aggregation, while Rab24 increased in the presence of protein inclusions. Amyloid-beta peptide also increased p-Tau accompanied by decreased proteasome and lysosome activity. PADK (lysosomal activator) treatment reverted the inhibition promoted by amyloidbeta peptide. Inhibition of proteasome leads to activation of lysosome, but lysosome inhibition does not affect proteasome. Overall, results suggest that targeting degradation pathways might be useful to understand, prevent and treat neurodegenerative diseases associated with protein deposits
APA, Harvard, Vancouver, ISO, and other styles
26

Smith, Steven Christopher. "The role of Ral GTPases and their targets in human bladder cancer." 2008. http://wwwlib.umi.com/dissertations/fullcit/3300267.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Seibold, Marcel. "Funktionelle Charakterisierung des Ras family small GTP binding protein RAL im Multiplen Myelom." Doctoral thesis, 2020. https://nbn-resolving.org/urn:nbn:de:bvb:20-opus-208003.

Full text
Abstract:
Die monoklonale Proliferation maligner Plasmazellen im Knochenmark ist charakteristisch für das multiple Myelom (MM) und kann bei Erkrankten zu Störungen in der Hämatopoese sowie zu Knochenläsionen und Niereninsuffizienz führen. Die Weiterentwicklung und der Einsatz neuer Therapieoptionen konnten das Überleben von MM-Patienten zwar erheblich verbessern, jedoch gilt diese Krankheit weiterhin als unheilbar. Onkogene Mutationen und das Knochenmarkmikromilieu führen in MM-Zellen zur Entstehung eines onkogenen Signalnetzwerks, das das Wachstum und Überleben der Zellen aufrechterhält. Mutationen der GTPase RAS treten bei bis zu 50 % der MM-Patienten auf und tragen zum Überleben von MM-Zellen bei. Trotz der Häufigkeit und Bedeutsamkeit von onkogenem RAS, auch in anderen Tumorentitäten, ist die GTPase nach wie vor therapeutisch nicht angreifbar. Die GTPase RAL aus der Familie der RAS-GTPasen wird als Downstream-Effektor von RAS angesehen, der damit ebenfalls zur Aufrechterhaltung des Tumorzellüberlebens beitragen könnte. In einigen Tumorentitäten konnte bisher gezeigt werden, dass eine Überexpression von RAL in den Tumorzellen vorliegt und die Proliferation und Apoptose von Tumorzellen durch RAL beeinflusst wird. Daher stellte sich die Frage, ob RAL im MM ebenfalls das Überleben von Tumorzellen beeinflusst und ob eine direkte Verbindung zwischen onkogenem RAS und RAL besteht. In dieser Arbeit wurde die funktionelle Rolle von RAL sowie dessen Zusammenhang mit onkogenem RAS im MM untersucht. Hierbei konnte eine Überexpression von RAL in MM-Zellen im Vergleich zu MGUS oder normalen Plasmazellen beobachtet werden. In Knockdown-Analysen wurde gezeigt, dass RAL überlebensnotwendig für MM-Zellen ist. Dabei wurde in Western Blot-Analysen festgestellt, dass diese Überlebenseffekte unabhängig von MAPK/ERK-Signaling vermittelt werden. Es konnte teilweise jedoch eine Abhängigkeit von der AKT-Aktivität beobachtet werden. Da RAL-Knockdown Einfluss auf das Überleben von MM-Zellen hat, wurde eine pharmakologische Inhibition von RAL durch den Inhibitor RBC8 untersucht. RBC8 zeigte in höheren Dosen nur bei einem Teil der MM-Zelllinien eine Wirkung auf das Zellüberleben sowie auf die RAL-Aktivierung. Die Weiterentwicklung potenter RAL-Inhibitoren ist daher für eine klinische Translation einer RAL-Inhibition von großer Bedeutung. Zur Untersuchung des Zusammenhangs zwischen onkogenem RAS und der RAL-Aktivierung wurden RAL-Pulldown-Analysen nach Knockdown von onkogenem RAS durchgeführt. In diesen Experimenten wurde keine Abhängigkeit der RAL-Aktivierung von onkogenem RAS festgestellt. Darüber hinaus zeigten Genexpressionsanalysen nach RAS- bzw. RAL-Knockdown unterschiedliche Genexpressionsprofile. In Massenspektrometrie-Analysen wurden mögliche Effektoren, die mit RAL an der Beeinflussung des Zellüberlebens beteiligt sein könnten, untersucht. Hierbei wurden die Komponenten des Exozyst-Komplexes EXO84 und SEC5 als Interaktionspartner von RAL identifiziert. Nachdem gezeigt wurde, dass RAL ausschlaggebend für das Überleben von MM-Zellen ist, wurde eine Kombination von RAL-Knockdown mit klinisch relevanten Wirkstoffen analysiert. Diese zeigte bei der Kombination mit PI3K oder AKT-Inhibitoren verstärkte Effekte auf das Zellüberleben der MM-Zellen. Zusammenfassend wurde die Bedeutung von RAL für das Überleben von Tumorzellen im MM gezeigt und RAL als potentielles therapeutisches Target im MM beschrieben, welches unabhängig von onkogenem RAS reguliert wird
Multiple myeloma (MM) is a hematologic neoplasia which is characterized by monoclonal proliferation of malignant plasma cells in the bone marrow leading to hematopoetic failure, bone lesions and renal failure. Although continuous development of existing therapeutics and new therapeutic options vastly improved MM patient survival, MM still remains an incurable disease. Oncogenic mutations and the bone marrow microenvironment contribute to a signaling network which sustains MM cell proliferation and survival. Within this network mutations of the RAS oncogene account for up to 50 % of MM patients. Despite its prevalence and importance not only in MM, RAS still remains undruggable. The GTPase-family Member RAL is considered as a RAS effector which might also influence maintainance of tumor cell survival. In several tumor entities RAL is overexpressed in tumor cells and influences proliferation and apoptosis. Therefore, in MM RAL might also be controlled by oncogenic RAS and mediate cell survival of tumor cells. In this work, RAL’s functional role as well as the potential interconnection with oncogenic RAS was investigated. In MM cells RAL is ovexpressed compared to non-malignant MGUS or plasma cells. Knockdown analyses showed that RAL is essential for MM cell survival. These survival effects are transferred independently of MAPK/ERK signaling as shown by Western Blot analysis. However, to some extent RAL influenced MM cell survival dependently of AKT activity. Because RAL knockdown had a significant effect on MM cell survival a pharmacological inhibition was tested using the inhibitor RBC8. In a portion of MM cell lines RBC8 exerts effects on cell survival. But the effects of RBC8 on RAL activation were only visible at higher concentrations as shown by pulldown assays. Thus, subsequent development of potent RAL inhibitors is of major importance for clinical translation. To investigate whether RAL is directly activated by oncogenic RAS, RAL pulldown assays were performed after knockdown of oncogenic RAS. Strikingly, there was no direct connection between the presence of oncogenic RAS and RAL activation. Furthermore, gene expression profiles after RAS or RAL knockdown showed differing expression signatures. Potential effectors of RAL which might also influence MM cell survival were investigated in mass spectrometric analyses where the exocyst complex components EXO84 and SEC5 were identified as RAL interaction partners. Since RAL is of importance for MM cell survival, RAL knockdown was combined with clinically relevant agents. There was an enhanced induction of apoptosis upon combination of PI3K or AKT inhibitors with RAL knockdown. Taken together, the influence of RAL as a crucial mediator of MM cell survival was shown in this work. Therefore, RAL represents a potential therapeutic target which is regulated independently of oncogenic RAS
APA, Harvard, Vancouver, ISO, and other styles
28

Park, Daeho. "BAI1 is an engulfment receptor for apoptotic cells upstream of ELMO1/Dock 180/Rac signal module /." Diss., 2008. http://wwwlib.umi.com/dissertations/fullcit/3312172.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Louis, Sharon Ann. "The effects of small GTP-binding proteins, Ras and Rap, on Dictyostelium Discoideum growth and differentiation." Thesis, 1996. http://hdl.handle.net/2429/6059.

Full text
Abstract:
It had been previously demonstrated that the expression of an activated rasD gene in Dictyostelium Ax3 cells (designated [Gl2T]rasD strain) resulted in formation of aggregates with multi-tips instead of the normal single tips, and a block in further development (Reymond et al., 1986, Nature 323:340-343). To investigate the role of activated RasD[G12T] during Dictyostelium development, cell type specific gene expression was examined in the [G12T]nzsD strain and found to be dramatically deregulated. The expression of prestalk cell specific genes ecmA and tagB was markedly enhanced, while the expression of the prespore cell specific gene cotC was reduced to low levels. By using a reporter gene linked to a prestalk cell specific promoter (ecmA/lacZ) to monitor the fate of cells in the multi-tipped aggregate, it appeared that most of the cells eventually adopted prestalk gene expression characteristics. When [G12T]rasD and wild type Ax3 cells were mixed and then induced to differentiate, chimeric pseudoplasmodia were not formed. Thus the defect in [G12T]rasD cells could not be corrected by mixing with wild type cells. Both stalk and spore cell formation could be induced in low cell density monolayers of the [G12T]rasD strain, suggesting that at least part of the inhibition of stalk and spore formation during development of the multi-tipped aggregates involved inhibitory cell interactions within the cell mass. Since it has been shown that Rap proteins are capable of antagonizing the effects of activated Ras proteins in mammalian cell lines, the ability of Dictyostelium rapl' to block the abnormal developmental phenotype of the [G12T]rasD strain was investigated. The rapl gene, a G12V activated and G10V negative mutant forms of rapl were independently linked to the rasD promoter and each construct used to transform [G12T]rasD strain. Transformants that expressed Rapl or Rapl[G12V] protein and maintained high levels of RasD[G12T], exhibited a modified phenotype. They still formed multi-tipped aggregates but most tips were able to complete development and form fruiting bodies. This phenotype was designated Multi-tipped Escape (ME). The rapl [G10V] construct did not modify the multi-tipped phenotype. Analysis of cell type specific gene expression in the ME cells showed that ecmA and tagB mRNA levels, which were enhanced in the [G12T]rasD strain, were restored to the levels seen in wild type cells. Furthermore, cotC mRNA which was dramatically lowered in the [G12T]rasD strain, was partially restored in the ME strain. However, the low expression of carl mRNA levels observed during the early development of [G12T]rasD strain was not restored by the overexpression of Rapl. There was also no increase in stalk and spore cell formation in monolayers of ME transformant compared to the [G12T]rasD strain. These data suggest that RasD[G12T] had two temporally separated effects during development, an early and a late defect, rapl appeared to only rescue the late defect in the [G12T]rasD strain, and the phenotype and gene expression data of the ME transformants were consistent with this idea. rapl appeared to have a general ability to antagonize the effects of activated ras genes in Dictyostelium since it also affected the phenotype of a strain overexpressing a growth phase dependent activated ras, rasG[G12T]. The overexpression of the rapl gene in the RasG-G12T cells partially suppressed the defect in aggregation and the cytoskeletal defect in these cells, but did not affect the cytokinesis defect, suggesting that the cytokinesis defect was distinct from the other two defects. The partial rescue in carl mRNA expression by Rapl, suggested that carl repression did not fully account for the aggregation deficiency in RasG-G12T cells.
APA, Harvard, Vancouver, ISO, and other styles
30

Anselmo, Sarah Straud. "Genetic analysis of grinder formation in Caenorhabditis elegans: regulation by RAB-6.2 and its GTPase activating protein EAT-17." 2004. http://edissertations.library.swmed.edu/pdf/AnselmoS121504/AnselmoSarah.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Chen, Ting. "Regulation of nuclear transport and mitosis by Ran GTPase /." 2007. http://gateway.proquest.com/openurl?url_ver=Z39.88-2004&res_dat=xri:pqdiss&rft_val_fmt=info:ofi/fmt:kev:mtx:dissertation&rft_dat=xri:pqdiss:3238148.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Topp, Justin David. "Characterizations of alsin and its role in IGF-1-mediated neuronal survival." 2005. http://edissertations.library.swmed.edu/pdf/ToppJ042905/ToppJustin.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

"The characterization of G-protein coupled receptors in isolated rat dorsal root ganglion cells." 2011. http://library.cuhk.edu.hk/record=b5894627.

Full text
Abstract:
Yeung, Barry Ho Sing.
Thesis (M.Phil.)--Chinese University of Hong Kong, 2011.
Includes bibliographical references (leaves 137-154).
Abstracts in English and Chinese.
Abstract --- p.i
論文摘要 --- p.iv
Acknowledgements --- p.vii
Publications based on work in this thesis. --- p.ix
List of abbreviations --- p.x
Chapter Chapter 1 --- Introduction --- p.1
Chapter 1.1 --- Dorsal root ganglion cells --- p.1
Chapter 1.1.1 --- Primary sensory neurons --- p.1
Chapter 1.1.2 --- Non-neuronal cells --- p.3
Chapter 1.1.2.1 --- Satellite glial cells --- p.3
Chapter 1.1.2.2 --- Schwann cells --- p.6
Chapter 1.2 --- Peripheral sensitization --- p.8
Chapter 1.3 --- Neuron-glia interactions --- p.9
Chapter 1.4 --- Aim of Thesis --- p.11
Chapter Chapter 2 --- "Materials, media, buffers and solutions" --- p.13
Chapter 2.1 --- Materials --- p.13
Chapter 2.2 --- "Culture media, buffer and solutions" --- p.19
Chapter 2.2.1 --- Culture media --- p.19
Chapter 2.2.2 --- General culture buffers and culture plate coating reagents --- p.19
Chapter 2.3 --- Antibodies used for identifying DRG cells --- p.23
Chapter 2.3.1 --- Primary antibodies --- p.23
Chapter 2.3.2 --- Secondary antibodies --- p.23
Chapter Chapter 3 --- Methods --- p.24
Chapter 3.1 --- Preparation of DRG cell cultures --- p.24
Chapter 3.2 --- Preparation of neuron-enriched and glial cell cultures --- p.25
Chapter 3.3 --- Immunocytochemistry --- p.26
Chapter 3.4 --- Immunohistochemistry --- p.27
Chapter 3.4 --- Determination of [3H]cAMP production in DRG cells --- p.28
Chapter 3.4.1 --- Principle of assay --- p.28
Chapter 3.4.2 --- Loading DRG cells with [3H]adenine --- p.28
Chapter 3.4.3 --- Column preparation --- p.28
Chapter 3.4.4 --- Measurement of [3H]cAMP production in DRG cells --- p.29
Chapter 3.4.5 --- Data analysis --- p.30
Chapter Chapter 4 --- Identification of DRG cells in dissociated cultures --- p.31
Chapter 4.1 --- Introduction --- p.31
Chapter 4.2 --- Aim of study --- p.34
Chapter 4.3 --- Results --- p.35
Chapter 4.3.1 --- Identification of DRG cells in isolated cultures --- p.35
Chapter 4.3.2 --- Activation and proliferation of glial cells in isolated cell cultures --- p.36
Chapter 4.3.3 --- Identification of glial cells in cultures --- p.38
Chapter 4.3.4 --- Modification of staining methods --- p.40
Chapter 4.3.5 --- Immunohistochemistry to identify DRG cells in DRG slices --- p.42
Chapter 4.3.6 --- Comparison of antibody staining in whole DRG and isolated DRG cells --- p.44
Chapter 4.4 --- Discussion --- p.44
Chapter 4.5 --- Summary --- p.53
Chapter Chapter 5 --- Characterization of GPCRs in isolated DRG cultures --- p.69
Chapter 5.1 --- Introduction --- p.69
Chapter 5.1.1 --- G-protein coupled receptors --- p.69
Chapter 5.1.2 --- Pharmacological characterization of prostanoid receptors on DRG cells --- p.73
Chapter 5.1.3 --- Gs- and Gi/o-coupled GPCRs in DRG cells --- p.75
Chapter 5.1.3.1 --- Gs-coupled GPCR: β-adrenoceptors --- p.76
Chapter 5.1.3.2 --- Gs-coupled GPCR: CGRP receptors --- p.79
Chapter 5.1.3.3 --- Gi/o-coupled GPCR: α2-adrenoceptors --- p.82
Chapter 5.1.3.4 --- Gi/o-coupled GPCR: Cannabinoid receptors --- p.85
Chapter 5.1.3.5 --- Gi/o-coupled GPCR: 5-HT1Areceptors --- p.88
Chapter 5.1.3.6 --- Gi/o-coupled GPCR: opioid and opioid-receptor-like 1 receptors --- p.90
Chapter 5.2 --- Aims of study --- p.93
Chapter 5.3 --- Results --- p.94
Chapter 5.3.1 --- Characterization of prostanoid receptors in isolated DRG cells --- p.94
Chapter 5.3.2 --- Characterization of CGRP receptors in isolated DRG cells --- p.96
Chapter 5.3.3 --- Investigation of the effect of CGRP8.37 on CGRP responses --- p.97
Chapter 5.3.4 --- Characterization of β1-adrenoceptors in isolated DRG cells --- p.97
Chapter 5.3.5 --- Characterization of β2-adrenoceptors in isolated DRG cells --- p.98
Chapter 5.3.6 --- Identification of β-adrenoceptor subtype mediating isoprenaline-stimulated responses.. --- p.99
Chapter 5.3.7 --- Characterization of α2-adrenceptors in isolated DRG cells --- p.100
Chapter 5.3.8 --- Characterization of cannabinoid 1 receptors in isolated DRG cells ... --- p.100
Chapter 5.3.9 --- Characterization of cannabinoid 2 receptors in isolated DRG cells --- p.101
Chapter 5.3.10 --- Characterization of 5-HT1A receptors in isolated DRG cells --- p.101
Chapter 5.3.11 --- Characterization of μ-opioid receptors in isolated DRG cells --- p.102
Chapter 5.3.12 --- Characterization of opioid-receptor-like 1 receptors in isolated DRG cells --- p.102
Chapter 5.3.13 --- Effect of nerve growth factor on DRG cells --- p.103
Chapter 5.4 --- Discussion --- p.106
Chapter 5.5 --- Summary --- p.114
Chapter Chapter 6 --- Conclusion and further studies --- p.134
References --- p.137
APA, Harvard, Vancouver, ISO, and other styles
34

Riddick, Gregory Parker. "Systems analysis of nuclear transport /." 2008. http://wwwlib.umi.com/dissertations/fullcit/3288362.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography